In last trading session, Lifecore Biomedical Inc (NASDAQ:LFCR) saw 0.76 million shares changing hands with its beta currently measuring 1.00. Company’s recent per share price level of $7.24 trading at $0.17 or 2.40% at ring of the bell on the day assigns it a market valuation of $266.63M. That closing price of LFCR’s stock is at a discount of -22.93% from its 52-week high price of $8.90 and is indicating a premium of 49.17% from its 52-week low price of $3.68. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.18 million shares which gives us an average trading volume of 172.68K if we extend that period to 3-months.
Lifecore Biomedical Inc (NASDAQ:LFCR) trade information
Upright in the green during last session for gaining 2.40%, in the last five days LFCR remained trading in the red while hitting it’s week-highest on Monday, 12/16/24 when the stock touched $7.24 price level, adding 8.12% to its value on the day. Lifecore Biomedical Inc’s shares saw a change of 16.96% in year-to-date performance and have moved -4.86% in past 5-day. Lifecore Biomedical Inc (NASDAQ:LFCR) showed a performance of -3.21% in past 30-days. Number of shares sold short was 2.34 million shares which calculate 11.2 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have assigned a consensus price target of 6.5 to the stock, which implies a fall of -11.38% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 8. It follows that stock’s current price would jump 30.94% in reaching the projected high whereas dropping to the targeted low would mean a gain of 30.94% for stock’s current value.
Lifecore Biomedical Inc (LFCR) estimates and forecasts
Statistics highlight that Lifecore Biomedical Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 43.94% of value to its shares in past 6 months, showing an annual growth rate of -65.00% while that of industry is 17.40. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 0.23% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 29.75M for the same. And 3 analysts are in estimates of company making revenue of 34.74M in the next quarter. Company posted 30.15M and 35.7M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 86.82% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -387.50% while estimates for its earnings growth in next 5 years are of 10.00%.
Lifecore Biomedical Inc (NASDAQ:LFCR)’s Major holders
Insiders are in possession of 5.43% of company’s total shares while institution are holding 69.84 percent of that, with stock having share float percentage of 73.85%. Investors also watch the number of corporate investors in a company very closely, which is 69.84% institutions for Lifecore Biomedical Inc that are currently holding shares of the company.
